Search research articles
Contact Us
Filters
Showing results (221-230 of 230) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 230 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Samuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
Jonathan A Coleman, Wesley Yip, Nathan C Wong, et al.
JCO Precision Oncology
|
May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
European Urology
|
September 26, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort
Viranda H Jayalath, Melissa Assel, Gopa Iyer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Philippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016
Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 230) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 230 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Samuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
Jonathan A Coleman, Wesley Yip, Nathan C Wong, et al.
JCO Precision Oncology
|
May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
European Urology
|
September 26, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort
Viranda H Jayalath, Melissa Assel, Gopa Iyer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Philippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016
Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Page
of 23